Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Lyons

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Pancreas|June 27, 2008
Clinical value of monitoring plasma octreotide levels during chronic octreotide long-acting repeatable therapy in carcinoid patientsEugene A Woltering, Vergilio A Salvo, Thomas M O'Dorisio, et al.
Obesity Surgery|July 5, 2007
An assay to measure angiogenesis in human fat tissueFrank L Greenway, Zhijun Liu, Ying Yu, et al.
The Journal of Trauma and Acute Care Surgery|November 14, 2023
TiME OUT: Time-specific machine-learning evaluation to optimize ultramassive transfusionCourtney H Meyer, Jonathan Nguyen, Andrew ElHabr, et al.
Epigenetics|September 21, 2016
Efficacy and epigenetic interactions of novel DNA hypomethylating agent guadecitabine (SGI-110) in preclinical models of hepatocellular carcinomaSimone Jueliger, John Lyons, Sara Cannito, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 21, 2013
A phase I and pharmacodynamic study of AT9283, a small-molecule inhibitor of aurora kinases in patients with relapsed/refractory leukemia or myelofibrosisJames Foran, Farhad Ravandi, William Wierda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2018
An Effective Epigenetic-PARP Inhibitor Combination Therapy for Breast and Ovarian Cancers Independent of BRCA MutationsNicholas Pulliam, Fang Fang, Ali R Ozes, et al.
Cancer Science|December 21, 2011
The heat shock protein 90 inhibitor, AT13387, displays a long duration of action in vitro and in vivo in non-small cell lung cancerBrent Graham, Jayne Curry, Tomoko Smyth, et al.
General Hospital Psychiatry|January 30, 2004
Consultation-Liaison Psychiatry Literature Database (2003 update). Part I: Consultation - Liaison Literature Database: 2003 update and national listsJames J Strain, Jay J Strain, Shawkat Mustafa, et al.
The Annals of Pharmacotherapy|April 26, 2017
Comparative Effectiveness and Safety Analysis of Dual Antiplatelet Therapies Within an Integrated Delivery SystemJames C Coons, Carlo J Iasella, Tyler Chanas, et al.
Journal of Gastrointestinal Cancer|May 11, 2011
A study of pipeline drugs in neuroendocrine tumorsCatherine T Anthony, Juan G Bastidas, Jessica L Thomson, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Pancreas|June 27, 2008
Clinical value of monitoring plasma octreotide levels during chronic octreotide long-acting repeatable therapy in carcinoid patientsEugene A Woltering, Vergilio A Salvo, Thomas M O'Dorisio, et al.
Obesity Surgery|July 5, 2007
An assay to measure angiogenesis in human fat tissueFrank L Greenway, Zhijun Liu, Ying Yu, et al.
The Journal of Trauma and Acute Care Surgery|November 14, 2023
TiME OUT: Time-specific machine-learning evaluation to optimize ultramassive transfusionCourtney H Meyer, Jonathan Nguyen, Andrew ElHabr, et al.
Epigenetics|September 21, 2016
Efficacy and epigenetic interactions of novel DNA hypomethylating agent guadecitabine (SGI-110) in preclinical models of hepatocellular carcinomaSimone Jueliger, John Lyons, Sara Cannito, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 21, 2013
A phase I and pharmacodynamic study of AT9283, a small-molecule inhibitor of aurora kinases in patients with relapsed/refractory leukemia or myelofibrosisJames Foran, Farhad Ravandi, William Wierda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2018
An Effective Epigenetic-PARP Inhibitor Combination Therapy for Breast and Ovarian Cancers Independent of BRCA MutationsNicholas Pulliam, Fang Fang, Ali R Ozes, et al.
Cancer Science|December 21, 2011
The heat shock protein 90 inhibitor, AT13387, displays a long duration of action in vitro and in vivo in non-small cell lung cancerBrent Graham, Jayne Curry, Tomoko Smyth, et al.
General Hospital Psychiatry|January 30, 2004
Consultation-Liaison Psychiatry Literature Database (2003 update). Part I: Consultation - Liaison Literature Database: 2003 update and national listsJames J Strain, Jay J Strain, Shawkat Mustafa, et al.
The Annals of Pharmacotherapy|April 26, 2017
Comparative Effectiveness and Safety Analysis of Dual Antiplatelet Therapies Within an Integrated Delivery SystemJames C Coons, Carlo J Iasella, Tyler Chanas, et al.
Journal of Gastrointestinal Cancer|May 11, 2011
A study of pipeline drugs in neuroendocrine tumorsCatherine T Anthony, Juan G Bastidas, Jessica L Thomson, et al.
Pageof 6